Melanoma and autoimmunity: spontaneous regressions as a possible model for new therapeutic approaches
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Dermatology,Oncology
Reference74 articles.
1. Recent advances of highly selective CDK4/6 inhibitors in breast cancer;Xu;J Hematol Oncol,2017
2. Molecular and cellular pathogenesis of melanoma initiation and progression;Regad;Cell Mol Life Sci,2013
3. Can cancer be reversed by engineering the tumor microenvironment?;Ingber;Semin Cancer Biol,2008
4. Biology of cancer; from cellular cancerogenesis to supracellular evolution of malignant phenotype;Motofei;Cancer Invest,2018
5. Scale of body pattern adjusts to available cell number in amphibian embryos;Cooke;Nature,1981
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clonal redemption of B cells in cancer;Frontiers in Immunology;2023-10-26
2. B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma;Nature Communications;2023-06-08
3. Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma;Frontiers in Molecular Biosciences;2022-04-14
4. Nobel Prize for immune checkpoint inhibitors, understanding the immunological switching between immunosuppression and autoimmunity;Expert Opinion on Drug Safety;2021-12-27
5. Results of combined nivolumab and ipilimumab therapy in patients with cancer;Meditsinskiy sovet = Medical Council;2021-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3